RJFSA
VBIV

Raymond James Financial Services Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Raymond James Financial Services Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,282
Closed -$29.8K – 3387
2023
Q1 		$29.8K Sell
3,282
-733
-18% -$10.4K ﹤0.01% 3159
2022
Q4 		$47.1K Sell
4,015
-156
-4% -$2.75K ﹤0.01% 3090
2022
Q3 		$88K Sell
4,171
-1,655
-28% -$44.6K ﹤0.01% 3016
2022
Q2 		$141K Sell
5,826
-3,079
-35% -$105K ﹤0.01% 2952
2022
Q1 		$443K Buy
8,905
+720
+9% +$35.6K ﹤0.01% 2457
2021
Q4 		$575K Buy
8,185
+769
+10% +$64.8K ﹤0.01% 2305
2021
Q3 		$692K Buy
7,416
+2,900
+64% +$276K ﹤0.01% 2168
2021
Q2 		$454K Buy
4,516
+277
+7% +$27K ﹤0.01% 2429
2021
Q1 		$395K Buy
4,239
+1,852
+78% +$188K ﹤0.01% 2450
2020
Q4 		$197K Sell
2,387
-1,996
-46% -$170K ﹤0.01% 2723
2020
Q3 		$376K Buy
4,383
+3,983
+996% +$464K ﹤0.01% 2153
2020
Q2 		$37K Sell
400
-1,433
-78% -$78.9K ﹤0.01% 2733
2020
Q1 		$52K Hold
1,833
– – ﹤0.01% 2313
2019
Q4 		$76K Buy
+1,833
New +$40.1K ﹤0.01% 2734

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raymond James Financial Services Advisors's VBIV Position: Q2 2023 in Review

Raymond James Financial Services Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 3,282 shares — an estimated $29.8K sold.

Raymond James Financial Services Advisors first reported a position in VBIV in Q4 2019 and held it in 14 quarters. The position peaked at $692K in Q3 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • Raymond James Financial Services Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 3,282 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $29.8K.
  • Raymond James Financial Services Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2019 and held it in 14 quarters.
  • Raymond James Financial Services Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $692K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2023, filed 25 Jul 2023.